Study Reveals Urolithin A May Treat Heart Failure by Boosting Mitophagy and Gut-Ceramide Pathways
A groundbreaking study has unveiled the therapeutic potential of Urolithin A, a natural compound, in combating heart failure with preserved ejection fraction (HFpEF), a complex cardiac condition
Read the full articleYou might also wanna read
Researchers Reverse Kidney Damage in Mice by Targeting Ceramide-Induced Mitochondrial Damage
Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that power kidney cells.
Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF
Conditions : Heart Failure, Preserved Ejection Fraction Interventions : Drug: Henggliflozin Combined with Probiotics; Drug: Henggliflozin; D
Mitochondria-derived vesicles with bioenergetic units from brown adipose tissue attenuate cardiac remodeling post-myocardial infarction
Study reveals mitochondria-derived vesicles from brown fat reduce cardiac remodeling post-heart attack by targeting macrophages, offering ne
Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection Fraction
Conditions : HFpEF - Heart Failure With Preserved Ejection Fraction Interventions : Behavioral: High-intensity interval training Sponsors :
IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron Deficiency
Conditions : Heart Failure With Preserved Ejection Fraction; Iron Deficiency Interventions : Drug: Ferric derisomaltose; Drug: Placebo (norm
FUEL FALD Study Published in Pediatric Cardiology
Mezzion Pharmaceuticals today announced publication of "The FUEL FALD Study: Effects of Udenafil on Liver Stiffness and Fibrosis after Fonta
Comments
Sign in to join the conversation.
No comments yet. Be the first.